VivoSim Labs, Inc. (LON:0R02)
London · Delayed Price · Currency is GBP · Price in USD 3.174
+0.065 (2.09%)
At close: Mar 20, 2025
VivoSim Labs Market Cap
VivoSim Labs has a market cap or net worth of 4.55 million as of October 24, 2025. Its market cap has decreased by -15.33% in one year.
Market Cap
4.55M
Enterprise Value
-1.64M
Revenue
103.65K
Ranking
n/a
PE Ratio
n/a
Stock Price
3.17
Market Cap Chart
Since February 14, 2012, VivoSim Labs's market cap has decreased from 36.80M to 4.55M, a decrease of -87.63%. That is a compound annual growth rate of -14.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 4.55M | -19.34% |
| Dec 31, 2024 | 5.64M | -33.94% |
| Dec 29, 2023 | 8.55M | -16.20% |
| Dec 30, 2022 | 10.20M | -56.31% |
| Dec 31, 2021 | 23.34M | -61.52% |
| Dec 31, 2020 | 60.65M | 73.13% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.78B |
| GSK plc | 66.21B |
| Haleon | 31.28B |
| Smith & Nephew | 11.67B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 3.92B |
| HUTCHMED (China) | 1.97B |
| Genus | 1.71B |